Aaron and Scott discuss the intricacies of insulin supply chain and manufacturing, shedding light on the time required for FDA approval. Aaron emphasizes the need for a regulatory process even for established drugs, providing insights into the complexities involved in the manufacturing and distribution of insulin.
